← Back to Search

Behavioural Intervention

TENS for Bedwetting

N/A
Recruiting
Led By Adam Howe, MD
Research Sponsored by Albany Medical College
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

Summary

This trial is testing whether a TENS unit, a machine that sends electrical signals through the skin, can help children with primary nocturnal enuresis, or bedwetting.

Who is the study for?
This trial is for children with primary nocturnal enuresis (bedwetting) more than once a week, who haven't improved with behavior changes. They must be able to follow the study plan and have not used drugs or other therapies for bedwetting in the last month. Kids with daytime wetting, less frequent bedwetting, secondary causes of bedwetting, heart disease, or conditions that make TENS use unsafe can't join.
What is being tested?
The study tests if TENS units at different pulse rates (2 Hz, 10 Hz, 150 Hz) help reduce bedwetting in kids. Participants are randomly assigned to one of three groups and use the TENS unit nightly for a month. Their progress is tracked through diaries and quality-of-life questionnaires before and after treatment.
What are the potential side effects?
Possible side effects from using the TENS unit may include skin irritation where electrodes are placed and discomfort from the electrical pulses. The intensity will be set to what each child feels sensitive to during office visits.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Percentage of wet nights
Secondary study objectives
Pediatric Incontinence Questionnaire (PIN-Q)
Severity of wet nights

Trial Design

3Treatment groups
Experimental Treatment
Group I: Pulse rate 2Hz (hertz)Experimental Treatment1 Intervention
electrodes placed per treatment arm, performed at bedtime, session time 15 min, frequency setting of 2 Hz, intensity setting to patient's tolerance, duration 30 days
Group II: Pulse rate 150HzExperimental Treatment1 Intervention
electrodes placed per treatment arm, performed at bedtime, session time 15 min, frequency setting of 150 Hz, intensity setting to patient's tolerance, duration 30 days
Group III: Pulse rate 10HzExperimental Treatment1 Intervention
electrodes placed per treatment arm, performed at bedtime, session time 15 min, frequency setting of 10 Hz, intensity setting to patient's tolerance, duration 30 days

Find a Location

Who is running the clinical trial?

Albany Medical CollegeLead Sponsor
92 Previous Clinical Trials
12,739 Total Patients Enrolled
Adam Howe, MDPrincipal Investigator - Albany Medical College
Albany Medical Center South Clinical Campus, Albany Medical College
2 Previous Clinical Trials
93 Total Patients Enrolled

Media Library

TENS Treatment (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04313192 — N/A
Bedwetting Research Study Groups: Pulse rate 2Hz (hertz), Pulse rate 150Hz, Pulse rate 10Hz
Bedwetting Clinical Trial 2023: TENS Treatment Highlights & Side Effects. Trial Name: NCT04313192 — N/A
TENS Treatment (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04313192 — N/A
~3 spots leftby Jan 2025